Keywords: b-ms, turnover, down, 2nd, quarter, bristol-myers, squibb
B-MS turnover down 14% in 2nd quarter
Article | 29 July 2002
Bristol-Myers Squibb has posted sales of $4.1 billion for second-quarter2002, a 14% decrease on the like, year-earlier period. Turnover included $394 million sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
